Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5370053 | 1.00 | ALDH1A1 (0.48) | ALDH1A1ALOX15LMNAHSD17B10PTPN1 | |
| SCHEMBL14906813 | 1.00 | ALDH1A1 (0.48) | ALDH1A1ALOX15LMNAHSD17B10PTPN1 | |
| SCHEMBL1073337 | 0.82 | ALDH1A1 (0.71) | ALDH1A1ALOX15PTPN1 | |
| SCHEMBL1073336 | 0.82 | ALDH1A1 (0.71) | ALDH1A1ALOX15PTPN1 | |
| SCHEMBL6250744 | 0.82 | ALOX15 (0.41) | ALDH1A1ALOX15LMNAHSD17B10CHRM5 | |
| Hydrogen Peroxide SCHEMBL31395241 | 0.80 | ALDH1A1 (0.63) | ALDH1A1ALOX15LMNAHSD17B10PTPN1 | |
| SCHEMBL14334247 | 0.79 | ALDH1A1 (0.47) | ALDH1A1ALOX15LMNAHSD17B10PTPN1 | |
| SCHEMBL14334248 | 0.79 | ALDH1A1 (0.47) | ALDH1A1ALOX15LMNAHSD17B10PTPN1 | |
| SCHEMBL7772775 | 0.79 | ALDH1A1 (0.47) | ALDH1A1ALOX15LMNAHSD17B10PTPN1 | |
| SCHEMBL1617620 | 0.79 | MGAM (0.43) | ALDH1A1ALOX15GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116005179-B | Method for preparing FCAA by electrochemical in-situ oxidation of FCA | 万华化学集团股份有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-116288433-A | Method for preparing FCAA by cathode-anode synergistic electrochemical oxidation of FCA | 万华化学集团股份有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-116005179-A | Method for preparing FCAA by electrochemical in-situ oxidation of FCA | 万华化学集团股份有限公司 | 2023-04-25 | — | — | CN | claimed |
| CN-116005179-B | Method for preparing FCAA by electrochemical in-situ oxidation of FCA | 万华化学集团股份有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-116288433-A | Method for preparing FCAA by cathode-anode synergistic electrochemical oxidation of FCA | 万华化学集团股份有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116005179-A | Method for preparing FCAA by electrochemical in-situ oxidation of FCA | 万华化学集团股份有限公司 | 2023-04-25 | — | — | CN | disclosed |
| EP-2723713-B1 | METHOD FOR MAKING NEW INTERMEDIATES FOR THE VITAMIN A AND -CAROTENE SYNTHESIS | DSM IP ASSETS BV (NL) | 2018-04-11 | — | — | EP | disclosed |
| EP-2723713-B1 | METHOD FOR MAKING NEW INTERMEDIATES FOR THE VITAMIN A AND -CAROTENE SYNTHESIS | DSM IP ASSETS BV (NL) | 2018-04-11 | — | — | EP | disclosed |
| EP-2723707-B1 | NEW ACID CHLORIDE | DSM IP ASSETS BV (NL) | 2017-10-25 | — | — | EP | disclosed |
| EP-2723707-B1 | NEW ACID CHLORIDE | DSM IP ASSETS BV (NL) | 2017-10-25 | — | — | EP | disclosed |
| US-9309194-B2 | Intermediates for the vitamin A and β-carotene synthesis | DSM IP ASSETS B.V. (NL) | 2016-04-12 | — | — | US | disclosed |
| WO-2012175398-A1 | NEW INTERMEDIATES FOR THE VITAMIN A AND β-CAROTENE SYNTHESIS | DSM IP ASSETS B.V. (NL) | 2012-12-27 | — | — | WO | disclosed |
| WO-2012175395-A1 | NEW ACID CHLORIDE | DSM IP ASSETS B.V. (NL) | 2012-12-27 | — | — | WO | disclosed |
| WO-2012175398-A1 | NEW INTERMEDIATES FOR THE VITAMIN A AND β-CAROTENE SYNTHESIS | DSM IP ASSETS B.V. (NL) | 2012-12-27 | — | — | WO | disclosed |
| US-7276622-B2 | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-10-02 | — | — | US | disclosed |
| US-20060173221-A1 | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-08-03 | — | — | US | disclosed |
| EP-1609777-A1 | METHOD FOR PRODUCING OXYGEN-CONTAINING COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2005-12-28 | — | — | EP | disclosed |
| EP-0673911-B1 | Process for producing optically active carboxylic acids and chiral ligands for this purpose | TAKASAGO PERFUMERY CO LTD (JP) | 1999-01-20 | — | — | EP | disclosed |
| US-5563295-A | HYDROGENATION OF OLEFINIC CARBOXYLIC ACID USING RUTHENIUM-PHOSPHINE COMPLEX CATALYST | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1996-10-08 | — | — | US | disclosed |
| EP-0673911-A1 | Process for producing optically active carboxylic acids and chiral ligands for this purpose | Takasago International Corporation (JP) | 1995-09-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173221-A1 | Method for producing oxygen-containing compound | GPX4, DUOX2, SCO2 | ALDH1A1 863/4885ALOX15 76/4885LMNA 4036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.